Geopolitical Tensions Escalate as Iran Refuses to Bow Trump Rejects Peace Offer Potentially Impacting Global Energy Markets Morgan Stanley Maintains Bullish Stance on NextEra Energy Despite Price Target Reduction Charter Communications Enhances Offer for Liberty Broadband in Buyout Deal Cantor Fitzgerald Maintains Overweight on Visa Following Latest Earnings Report Surge in Treasury Yields Reshapes Bond Market Landscape Investors Seek New Opportunities Meta Could Enter Cloud Computing Business as Data Center Overcapacity Looms Zuckerberg Says APC Q1 2026 Earnings EPS Beats Estimates Amid Revenue NonDisclosure Stock Slides Dine Brands Q1 2026 Earnings EPS Beats Estimates by 53 Amid Operational Discipline Polaris Q1 2026 Earnings Massive EPS Surprise Defies Gloomy Expectations RTX Q1 2026 Earnings Strong EPS Beat Drives Modest Share Gain STERIS plc STE Q1 2026 Earnings EPS Misses Estimates as Stock Dips Slightly Cadrenal Therapeutics Q1 2026 Earnings Narrowed Loss Surpasses Estimates Stock Edges Higher Fusemachines FUSE Holds Steady Near 142 as Key Levels Come into Focus Asia Pacific Wire Cable APWC Edges Lower as Stock Holds Near Key Support Zone High Roller Technologies ROLR Gains 269 as Stock Bounces from Support ICU Medical Inc ICUI Rises Modestly as Technicals Suggest RangeBound Trading Gilead Sciences GILD Edges Higher Modestly as Shares Hold Above Key Support GXAI Q1 2026 Earnings EPS Misses Estimates by 1765 Stock Declines Dynatrace DT Q1 2026 Earnings Software Firm Beats EPS Expectations Shares Gain 53 Arch Capital Group Q1 2026 Earnings EPS Misses Consensus by a Small Margin Shares Edge Higher ZDGE Q1 2026 Earnings EPS Miss Weighs on Stock ATYR Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Milestones Approach QTTB Q1 2026 Earnings EPS Beat Amid Clinical Progress Stock Declines on Cash Concerns Treasury Yield Surge Challenges RiskFree Label Opens Opportunities in Intermediate BBB and HighYield Bonds SLVM Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Industry Headwinds Beam Therapeutics BEAM Rises 35 as Gene Editing Sector Gains Traction